hotspot -WSS

hotspot

author：fashion 2025-10-01 01:50:31 - browse：57

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Hyaluronic acid injections don’t help knee osteoarthritis, study finds

leisure time

WSS

Eli Lilly expects to double planned employment in Boston center

STAT Summit: GSK CEO on pharma giant's new direction

Hospital price transparency does save money, advocate argues

HHS leader on health, climate change and biopharma emissions

What to know about Saharan dust affecting the US and how it can affect health

Death toll from an explosion and collapse of a Paris building in June climbs to 3

entertainment

hotspot

hotspot

Affirmative action in medical school literally saved lives

First Opinion Podcast: Long Covid needs a new approach

Alkermes shareholders re

FDA warns J&J's Abiomed: We will regulate your software

Medicare proposal to cover medical devices draws a mixed reaction

In new study, freeze

Affirmative action in medical school literally saved lives

Impact of Dobbs ruling felt at reproductive medicine meeting

Supreme Court strikes down use of affirmative action

Medicare reduced heart disease by changing how it pays doctors

focus

Elizabeth Warren probes abortion access

Eli Lilly expects to double planned employment in Boston center

Why health workers in Gaza are injured or die at high rates

AbbVie dramatically boosts its spending on lobbying

STAT Summit: Biotech founders on deal

Review: 'Barbie' will hit you like a shot in the heart

leisure time

leisure time

Wikipedia

knowledge